Fasting insulin, decoded.

The editorial TLDR.

What insulin actually is.

Insulin is a small peptide hormone produced by the beta cells of the pancreas. Its primary job is to lower blood glucose — to take the sugar that arrives in your bloodstream after eating and shuttle it into the cells of your muscles, liver and fat tissue, where it's either burned for energy or stored. Insulin also tells the liver to stop making new glucose, suppresses fat breakdown, and supports protein synthesis in muscle.

The system is built around feedback. Eat carbohydrate, blood glucose rises, the pancreas releases insulin, glucose drops, insulin returns to baseline. In a healthy system, this loop is fast and tight. The "fasting" version — measured after an overnight fast of at least 8 hours — captures the baseline tone: how much insulin your pancreas needs to keep glucose steady when no food is incoming.

"Fasting glucose tells you what your blood sugar is. Fasting insulin tells you how hard your body had to work to keep it there."

This distinction is the entire reason fasting insulin matters as a women's-health marker. As cells become less responsive to insulin's signal — the early stage of insulin resistance — the pancreas compensates by producing more insulin. Fasting glucose can stay perfectly normal for years while fasting insulin quietly climbs. By the time fasting glucose drifts upward, the underlying pattern has often been brewing for a decade. HbA1c, the 90-day average of blood glucose, moves later still.

Standard U.S. labs measure fasting insulin with an immunoassay. The result can be combined with fasting glucose to calculate HOMA-IR (Homeostatic Model Assessment of Insulin Resistance), a simple ratio that many clinicians find more useful than either number alone for picking up early insulin resistance.

Why fasting insulin matters for women.

The U.S. mainstream diabetes pathway is built around fasting glucose and HbA1c. Both are useful — but both are lagging indicators. Fasting insulin moves earlier, and the patterns that matter most clinically in women often live in that earlier window.

PCOS. Roughly one in ten U.S. women of reproductive age has polycystic ovary syndrome, and insulin resistance is one of the central drivers in the majority of cases. High fasting insulin pushes ovarian androgen production up and SHBG down — increasing free testosterone, contributing to cycle disruption, acne, hair changes and weight-loss resistance. A fasting insulin under 10 alongside a normal glucose looks reassuring; a fasting insulin of 18 with that same normal glucose is a different story, and a common one in PCOS.

Perimenopause and menopause. The estrogen decline of the menopause transition is associated with reduced insulin sensitivity — a shift the literature has documented repeatedly. Many women who maintained stable weight and energy in their thirties find themselves gaining weight (particularly around the abdomen), feeling more energy-crashed after meals, and watching their lipid panel drift, even without changing what they eat. Fasting insulin often moves before fasting glucose does, which is why it's worth a baseline in the late thirties or early forties.

Gestational diabetes and postpartum metabolic risk. A history of gestational diabetes meaningfully increases lifetime risk of type 2 diabetes. Fasting insulin in the years after pregnancy can pick up insulin resistance long before the standard screen would flag it.

Cardiovascular risk in women. Insulin resistance is a stronger predictor of cardiovascular events in women than in men, by some analyses. The pattern is often missed because traditional cardiovascular risk scoring leans on cholesterol and blood pressure — both of which can stay reassuring while insulin is doing the underlying damage.

Fatty liver. Metabolic-associated fatty liver disease (formerly NAFLD) is rising in women and is closely tied to insulin resistance. Fasting insulin, alongside ALT and waist-to-height ratio, is often the earliest fingerprint.

What the ranges generally mean.

Most U.S. labs report fasting insulin in µIU/mL. Reference ranges are wide; the broad shape below is common for non-pregnant adult women.

Illustrative ranges, not diagnostic. Reference ranges vary by laboratory; clinical interpretation depends on glucose, HbA1c and the broader metabolic picture. Always discuss your specific result with a qualified healthcare provider.

What may drive fasting insulin elevated.

The patterns below come up most often when fasting insulin reads higher than the comfortable zone in U.S. women.

What may drive fasting insulin elevated.

• Insulin resistance. The cells of the body become less responsive to insulin's signal, so the pancreas compensates by making more. This is the dominant driver behind most elevated readings.
• Polycystic ovary syndrome. Insulin resistance is a central feature of most PCOS presentations. Elevated fasting insulin often precedes the reproductive-symptom picture.
• Excess visceral adipose tissue. Fat stored around the organs is metabolically active and drives insulin resistance independently of BMI. Many women with elevated fasting insulin sit at a normal BMI.
• Perimenopause and menopause-era shifts. Estrogen decline is associated with reduced insulin sensitivity. The pattern often shows up in the late forties.
• Chronic stress and sleep disruption. High cortisol and poor sleep both impair insulin sensitivity over time.
• Highly processed, high-refined-carbohydrate diet. Persistent high-glycemic-load eating drives chronically elevated insulin demand.
• Sedentary lifestyle. Skeletal muscle is the body's single largest insulin-sensitive tissue. Lower muscle activity reduces glucose uptake.
• Certain medications. Glucocorticoids (oral, topical, inhaled), atypical antipsychotics and some beta-blockers can raise insulin demand.
• Family history and genetics. Some women are constitutionally more prone to insulin resistance — particularly those with a strong family history of type 2 diabetes.

What may drive fasting insulin low.

• Healthy insulin sensitivity. The most common reason. A low-normal fasting insulin with a normal fasting glucose is generally a favorable finding.
• Prolonged fasting or very-low-carbohydrate eating. Sustained low-carb eating reduces baseline insulin demand. Worth context when interpreting.
• Late-stage beta-cell exhaustion. In late type 2 diabetes, the pancreas can lose the capacity to make insulin. Fasting insulin may be low alongside elevated glucose — a different and more clinically urgent picture.
• Type 1 diabetes. Autoimmune destruction of the insulin-producing cells. Fasting insulin is typically very low alongside high glucose.

Your provider will guide the conversation based on your full medical context. These prompts are designed to make sure fasting insulin actually gets ordered — not just glucose and HbA1c.

When to test, and how it's measured.

The fasting insulin test is a standard venous blood draw. Fasting is required — at least 8 hours, ideally 10–12 hours, of nothing but water before the draw. Coffee, even black, is best avoided as it can shift the result modestly.

Timing during the day matters less than the fasting state itself, but most labs prefer a morning draw, which makes the fasting requirement easiest to meet. Cycle day generally doesn't matter for fasting insulin, though many women's-health panels bundle insulin with cycle-day-3 hormones for convenience.

If you are on metformin, GLP-1 receptor agonists (semaglutide, tirzepatide) or any other glycemic medication, mention it on the requisition — these meaningfully shift the read. Acute stress, recent illness, a poor night of sleep or heavy alcohol the night before can all transiently elevate insulin; if the number comes back unexpectedly high, a recheck is reasonable.

Fasting insulin is most informative when paired with fasting glucose, HbA1c, and a basic lipid panel — together they describe the metabolic picture. HOMA-IR (insulin × glucose / 405) is a simple calculation that turns the two numbers into a single insulin-resistance score. Some labs will report it automatically; many will not.

Direct-to-consumer at-home tests — Function Health, LetsGetChecked, Quest Direct's comprehensive metabolic panels — include fasting insulin in their broader metabolic and women's-health sets. They're useful for a baseline; they don't replace the clinical conversation. For the trade-offs across services, see our guide to at-home blood tests for women.

Related biomarkers worth understanding.

Fasting insulin rarely sits alone in a thoughtful metabolic workup. The markers below come up most often alongside it.

• HbA1c — the 90-day average of blood glucose. The lagging indicator that moves after fasting insulin does.
• ApoB — the modern, more accurate measure of atherogenic particle burden. Often elevated alongside insulin resistance.
• Lipids (full panel) — triglycerides and HDL move with insulin sensitivity. Elevated triglyceride-to-HDL ratio is a common insulin-resistance signature.
• SHBG — low SHBG is one of the most reliable markers of underlying insulin resistance in women.
• Testosterone — insulin drives ovarian androgen production. Elevated free testosterone alongside elevated insulin is a recognizable PCOS pattern.
• hsCRP — low-grade inflammation often travels alongside insulin resistance.